NCT07003880 - Penthrox in Otolaryngology | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

June 1, 2027

Conditions

All Adult Patients Undergoing an Otolaryngology Procedure With Inhaled Methoxyflurane as an Adjunct to Topical or Local Anesthesia

Interventions

DRUG

Methoxyflurane anesthesia

A single Penthrox (3mL) self-inhaler will be administered 5-minutes prior to the onset of the procedure, before local anesthesia. Patients will undergo the procedure, have post-procedural vital signs, and remain in clinic for observation for 30 minutes post-procedure per our usual post-procedure monitoring.

All Listed Sponsors

lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER